Cesarean Delivery Withdrawn Phase 4 Trials for Gabapentin (DB00996)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03335436Gabapentin in the Post-cesarean Pain Management of Buprenorphine PatientTreatment